Secukinumab efficacy and safety in indian patients with moderate-to-severe plaque psoriasis: Sub-analysis from FIXTURE, a randomized, placebo-controlled, phase 3 study

Secukinumab efficacy and safety in indian patients with moderate-to-severe plaque psoriasis: Sub-analysis from FIXTURE, a randomized, placebo-controlled, phase 3 study

Title: Secukinumab efficacy and safety in Indian patients with moderate-to-severe plaque psoriasis: sub-analysis from FIXTURE (Full Year Investigative Examination of Secukinumab vs. Etanercept Using Two Dosing Regimens to Determine Efficacy in Psoriasis), a randomized, placebo-controlled, phase 3 st...

Full description

Bibliographic Details
Main Authors: Ramesh M Bhat, B Leelavathy, Sacchidanand S Aradhya, Maragondanahalli G Gopal, D. V. S. Pratap, Mir Mubashir, Putta Srinivas, Sushil Y Pande, Amit S Thavkar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Dermatology Online Journal
Subjects:
Interleukin (IL)-17A
PASI 75
plaque psoriasis
secukinumab
Online Access:http://www.idoj.in/article.asp?issn=2229-5178;year=2017;volume=8;issue=1;spage=16;epage=24;aulast=Bhat

Internet

http://www.idoj.in/article.asp?issn=2229-5178;year=2017;volume=8;issue=1;spage=16;epage=24;aulast=Bhat

Similar Items